Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara)

CompletedOBSERVATIONAL
Enrollment

143

Participants

Timeline

Start Date

February 5, 2020

Primary Completion Date

June 24, 2020

Study Completion Date

June 24, 2020

Conditions
HypoparathyroidismQuality of Life
Interventions
OTHER

Non-interventional study

Non-interventional study

Trial Locations (6)

44000

CHU Nantes, Nantes

49100

CHU Angers, Angers

54511

CHU Nancy, Nancy

72037

Centre Hospitalier Le Mans, Le Mans

75013

AP-HP La Pitié Salpétrière, Paris

87042

CHU Limoges, Limoges

All Listed Sponsors
collaborator

University Hospital, Angers

OTHER_GOV

collaborator

Centre Hospitalier le Mans

OTHER

collaborator

University Hospital, Limoges

OTHER

collaborator

Central Hospital, Nancy, France

OTHER

collaborator

Pitié-Salpêtrière Hospital

OTHER

lead

Nantes University Hospital

OTHER

NCT04053647 - Quality of Life Evaluation (SF-36) in Patients With Permanent Hypoparathyroidism After Total Thyroidectomy (Qol-Hypopara) | Biotech Hunter | Biotech Hunter